Synthesis of (S)-N-hydantoinoalkylglycoluriles by one-pot double cyclisation of chiral α,ω-diureido acids under the action of 4,5-dihydroxyimidazolidin-2-ones
摘要:
The reaction of 4,5-dihydroxyimidazolidin-2-ones with chiral (S)-N,N'-dicarbamoyl-alpha,omega-amino acids occurs as one-pot double cyclisation under acid catalysis to give the corresponding glycoluriles with (S)-N-hydantoinoalkyl substituents.
[EN] CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS<br/>[FR] CONJUGUÉS POUR TRAITER LES MALADIES PROVOQUÉES PAR DES CELLULES EXPRIMANT PSMA
申请人:ENDOCYTE INC
公开号:WO2014078484A1
公开(公告)日:2014-05-22
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
申请人:ENDOCYTE, INC.
公开号:US20150297735A1
公开(公告)日:2015-10-22
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
Verfahren zur Decarbamoylierung von N-cabamoylgeschützten Verbindungen, neue Carbonsäureanhydride und deren Verwendung
申请人:Degussa-Hüls Aktiengesellschaft
公开号:EP1024133A2
公开(公告)日:2000-08-02
Verfahren zur Decarbamoylierung von N-carbamoylgeschützten Verbindungen, neue Carbonsäureanhydride und deren Verwendung.
Die Erfindung richtet sich auf ein Verfahren zur Decarbamoylierung von N-carbamoylgeschützten Verbindungen der allgemeinen Formel (I)
mittels Stickoxiden der allgemeinen Formel (II)
NxOy II.
Durch diese Reaktion können neue vormals nicht herstellbare Carbonsäureanhydride der allgemeinen Formel (III)
generiert werden.
Verwendung der erfindungsgemäßen Anhydride in der Synthese bioaktiver Wirkstoffe und zur Herstellung von Polyaminosäuren.
PSMA LIGAND-CONTAINING CONJUGATES FOR THE TREATMENT OF PROSTATE CANCER
申请人:Endocyte, Inc.
公开号:EP3858341A1
公开(公告)日:2021-08-04
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.